论文部分内容阅读
目的:观察分析肺泡表面活性物质(PS)用于治疗新生儿呼吸窘迫综合征的临床效果。方法:选择50例呼吸窘迫综合征的新生儿患者按照治疗方法的不同随机分为对照组和观察组,比较两组新生儿患者的临床疗效。结果:治疗后观察组PaCO2显著下降,PaO2、血气pH明显上升,差异均有统计学意义(P<0.05);观察组的临床总有效率明显高于对照组(P<0.05)。结论:肺泡表面活性物质用于新生儿呼吸窘迫综合征有显著的效果,值得临床推广。
Objective: To observe and analyze the clinical effect of alveolar surfactant (PS) in the treatment of neonatal respiratory distress syndrome. Methods: Fifty newborn infants with respiratory distress syndrome were randomly divided into control group and observation group according to the different treatment methods. The clinical efficacy of two groups of newborns was compared. Results: After treatment PaCO2 significantly decreased PaO2, blood gas pH was significantly increased, the difference was statistically significant (P <0.05); observation group, the total effective rate was significantly higher than the control group (P <0.05). Conclusion: Alveolar surfactant for neonatal respiratory distress syndrome has a significant effect, which is worthy of clinical promotion.